Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~Male or female patient older than 18 years. Adult patient diagnosed with stage IIIb/IV NSCLC locally advanced or metastatic, with activating mutation(s) of EGFR and who is EGFR-TKI naïve.~Patient for whom a decision of treatment with afatinib monotherapy has been taken in the frame of its marketing authorization.~Out-patient. Patient having given written consent for participation in the study. Patient who is able to participate in the investigator's opinion. Patient affiliated with the French social security.~Exclusion criteria:~Patients participating in an interventional clinical study. Patients for whom a participation in an interventional clinical study is foreseen within 3 months following the study inclusion.~Patients participating in a therapeutic education program.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- group 1 (Type: None): Group without 'remote additional personalised nurse-led follow-up: patients will receive the healthcare given routinely by their medical team
- group 2 (Type: None): Group with 'remote additional personalised nurse-led follow-up: patients will receive telephone calls from a nurse in addition to the healthcare given routinely by their medical team

Based on this trial design, predict the completion outcome and termination type (if applicable).